The field of gene therapy, which has promised a great the control of mutation rate in viruses. The RNA viruses are unique and live on the edge of their "error threshold", deal, but only produced limited successes in the twentieth century, will depend upon the development of virus which means that their mutation rates and their rate of evolution will be a big problem in our future. Viruses of vectors in the twenty-first century. Recombinant and mutant viruses will be used in vaccines, in gene replaceour evolutionary past (retroviruses) may comprise 1%-10% of our genome. Did they play a role in our evolution ment therapy, and for the selective killing of tumor cells in people. Viral agents that cause old diseases will be and have we overlooked their role in disease? What is their impact upon our diversity, immune response, or uncovered, perhaps for type I diabetes, multiple sclerosis, or other neurological syndromes. Viruses that have response to other viruses? Finally, viruses will continue to be the tools in our evolved a way to enhance or inhibit inflammatory reactions, immunosuppress the host, or evade an immune ever-expanding revolution in the biological sciences. Basic science laboratories will continue to utilize viral response will be characterized and understood. These very viral genes and approaches will then be applied to genes and enzymes, viral promoters, viral proteins, and viral capsids to explore the fundamental questions relieve autoimmune diseases in humans.
But surely viruses will continue to lead the way in of life processes. The twenty-first century will provide new challenges both to the viruses and to the virolothe basic sciences, as well as in clinical sciences. Great questions remain in virology and its research gists.
